Evaxion Biotech AS (EVAX)
4.18
+0.06
(+1.46%)
USD |
NASDAQ |
Apr 26, 16:00
4.13
-0.05
(-1.20%)
After-Hours: 20:00
Evaxion Biotech Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | -23.79M |
| March 31, 2022 | -26.08M |
| December 31, 2021 | -21.93M |
| September 30, 2021 | -22.24M |
| Date | Value |
|---|---|
| June 30, 2021 | -18.71M |
| March 31, 2021 | -13.52M |
| December 31, 2020 | -12.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-26.08M
Minimum
Mar 2022
-12.44M
Maximum
Dec 2020
-19.82M
Average
-21.93M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Ascendis Pharma A/S | -505.97M |
| DBV Technologies SA | -79.65M |
| Cellectis SA | -65.68M |
| Adaptimmune Therapeutics PLC | -140.88M |
| Akari Therapeutics PLC | -- |